The New Role of HNF1A-NAS1/miR-214/INHBA Signaling Axis in Colorectal Cancer
Frontiers in Bioscience-Landmark · 2023
DOI: 10.31083/j.fbl2811301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2023. Verfasst von Xuan Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, 650118 Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Adenocarcinoma, Colonic Neoplasms, Colorectal Neoplasms, MicroRNAs. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Scientific Research Fund of Yunnan Provincial Education Department, Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) is the third most common cancer and one of the leading causes of death worldwide. Seriously threatens human life and health. Previous studies have identified that inhibin βA (INHBA) could induce tumorgenesis and progression of CRC through the regulation of the TGF-β/Smad signal axis. The abnormal expression of INHBA is related to the poor prognosis of patients. The aim of this study was to identify the molecular mechanism of HNF1A-AS1 and miR-214 regulating INHBA and carcinogenesis through bioinformatics combined with experiments.
Methods
The expression of HNF1A-AS1, miRNA-214-5p, INHBA in pan-cancer and CRC were investigated in the Cancer Genome Atlas (TCGA). The correlation between HNF1A-AS1 and immune-related genes or miRNAs was explored via the Gene Expression Profiling Interactive Analysis (GEPIA) and volcano plots, respectively. The association between HNF1A-AS1 and differentially expressed miRNAs was constructed by TargetScan. The miRDB, miRWalk, and TargetScan databases were utilized to predict the target genes of hsa-miR-214. The expression of INHBA in tissues and cell lines of CRC was examined by RT-qPCR and western blot assay.
Results
The INHBA and HNF1A-AS1 expressions were increased in Colon adenocarcinoma (COAD) and Rectum adenocarcinoma (READ) of the TCGA database. Hsa-miR-214 was relatively less expressed in CRC tissues compared with para-cancer tissues. The expression of HNF1A-AS1 was negatively correlated with hsa-miR-214. INHBA was one of the target genes of hsa-miR-214 based on miRDB, miRWalk, and TargetScan databases. The specific binding sites of INHBA-3’UTR and miR-214-5p were identified by starBase. The expression level of INHBA was positively correlated with the T stage of tumor and negatively correlated with overall survival (OS) and disease-free survival (DFS) in CRC patients. The results of RT-qPCR and western blot indicated that the expression of INHBA in tissues and cell lines in CRC was higher than those in para-carcinoma tissues and normal colon cell lines, respectively.
Conclusions
These findings suggested that HNF1A-AS1 and miRNA-214-5p were key upstream non-coding RNAs of INHBA. The HNF1A-AS1/miR-214/INHBA signal axis plays a significant role in the tumorgenesis and progression of CRC. By interfering with HNF1A-AS1 and INHBA genes on HT29 and SW480 cells, it was found that HNF1A-AS1 and INHBA genes may be important target genes in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, 650118 Kunming, Yunnan, China.
- Department of Head and Neck Tumor Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, 650118 Kunming, Yunnan, China.
- Laboratory of Molecular Diagnosis Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, 650118 Kunming, Yunnan, China.
- Department of Hospital Affairs, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, 650118 Kunming, Yunnan, China.
- Department of Oncology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, 650118 Kunming, Yunnan, China.
- Department of Minimally Invasive Intervention, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, 650118 Kunming, Yunnan, China.
Förderung
- National Natural Science Foundation of China
- Scientific Research Fund of Yunnan Provincial Education Department
- Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University
- Innovation Fund for Doctoral Students of Kunming Medical University
Zitieren
APA
Zhang, X., Wu, T., Qin, R., Cai, X., Zhou, Y., Wang, X., Shang, Z., Li, G., Yang, R., Dong, C., Li, J., Ren, Y., Ding, R., & Li, Y. (2023). The New Role of HNF1A-NAS1/miR-214/INHBA Signaling Axis in Colorectal Cancer. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2811301
Vancouver
Zhang X, Wu T, Qin R, Cai X, Zhou Y, Wang X, et al. The New Role of HNF1A-NAS1/miR-214/INHBA Signaling Axis in Colorectal Cancer. Frontiers in Bioscience-Landmark. 2023. doi:10.31083/j.fbl2811301
BibTeX
@article{Zhang2023,
author = {Zhang, Xuan and Wu, Tao and Qin, Rujia and Cai, Xinyi and Zhou, Yongchun and Wang, Xiaoxiong and Shang, Zhongjun and Li, Guoyu and Yang, Renfang and Dong, Chao and Li, Jinsha and Ren, Yongping and Ding, Rong and Li, Yunfeng},
title = {The New Role of HNF1A-NAS1/miR-214/INHBA Signaling Axis in Colorectal Cancer},
journal = {Frontiers in Bioscience-Landmark},
year = {2023},
doi = {10.31083/j.fbl2811301}
}
EUVIMED